Aitheroscope is an AI-based medical software that detects asymptomatic atherosclerosis from a single retinal image, a quick and non-invasive test that can be performed in primary care with a standard retinal camera. The retina is the only place in the body where blood vessels can be observed directly, and changes in its microvasculature reflect the state of the arteries. Aitheroscope combines convolutional neural networks and Vision Transformers in an ensemble model that analyses these patterns and returns a result in under 10 seconds, with an interpretable report for the clinician. It can work from the image alone or be enhanced with a few clinical variables. Clinically validated and published in European Heart Journal – Digital Health, it reaches over 93% sensitivity and over 85% specificity, with equivalent performance in women and men, far above current risk calculators. Positive cases are referred for confirmation and preventive management. Aitheroscope is already used in 21 healthcare centres across Spain, Mexico and Chile, with more than 12,000 patients screened, and is delivered as a web application or via API, fitting easily into existing clinical workflows.